Taken together, these results suggest a non-trivial regulatory model at this site, which may involve channeling SE action on the DSCAM-AS1 promoter in cancer cells overexpressing ERα due to strict domain definition by CTCF. The gene discussed is DSCAM; the disease is cancer.